BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24860503)

  • 1. H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice.
    Vercellotti GM; Khan FB; Nguyen J; Chen C; Bruzzone CM; Bechtel H; Brown G; Nath KA; Steer CJ; Hebbel RP; Belcher JD
    Front Pharmacol; 2014; 5():79. PubMed ID: 24860503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.
    Vercellotti GM; Zhang P; Nguyen J; Abdulla F; Chen C; Nguyen P; Nowotny C; Steer CJ; Smith A; Belcher JD
    Mol Med; 2016 Sep; 22():437-451. PubMed ID: 27451971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease.
    Belcher JD; Vineyard JV; Bruzzone CM; Chen C; Beckman JD; Nguyen J; Steer CJ; Vercellotti GM
    J Mol Med (Berl); 2010 Jul; 88(7):665-75. PubMed ID: 20306336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
    Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
    Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice.
    Belcher JD; Young M; Chen C; Nguyen J; Burhop K; Tran P; Vercellotti GM
    Blood; 2013 Oct; 122(15):2757-64. PubMed ID: 23908468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
    PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
    Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
    Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
    Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
    Front Immunol; 2020; 11():613278. PubMed ID: 33542720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
    Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
    Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
    Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
    PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice.
    Belcher JD; Mahaseth H; Welch TE; Otterbein LE; Hebbel RP; Vercellotti GM
    J Clin Invest; 2006 Mar; 116(3):808-16. PubMed ID: 16485041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease.
    Belcher JD; Nataraja S; Abdulla F; Zhang P; Chen C; Nguyen J; Ruan C; Singh M; Demes S; Olson L; Stickens D; Stanwix J; Clarke E; Huang Y; Biddle M; Vercellotti GM
    Front Med (Lausanne); 2023; 10():1101501. PubMed ID: 37144034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
    PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferritin heavy chain mediates the protective effect of heme oxygenase-1 against oxidative stress.
    Cheng HT; Yen CJ; Chang CC; Huang KT; Chen KH; Zhang RY; Lee PY; Miaw SC; Huang JW; Chiang CK; Wu KD; Hung KY
    Biochim Biophys Acta; 2015 Dec; 1850(12):2506-17. PubMed ID: 26423448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HO-1
    Liu Y; Jing F; Yi W; Mendelson A; Shi P; Walsh R; Friedman DF; Minniti C; Manwani D; Chou ST; Yazdanbakhsh K
    Blood; 2018 Apr; 131(14):1600-1610. PubMed ID: 29437594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence.
    Gentinetta T; Belcher JD; Brügger-Verdon V; Adam J; Ruthsatz T; Bain J; Schu D; Ventrici L; Edler M; Lioe H; Patel K; Chen C; Nguyen J; Abdulla F; Zhang P; Wassmer A; Jain M; Mischnik M; Pelzing M; Martin K; Davis R; Didichenko S; Schaub A; Brinkman N; Herzog E; Zürcher A; Vercellotti GM; Kato GJ; Höbarth G
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthetic supra plasma expanders: a new class of therapeutics to improve microcircualtion in sickle cell anaemia.
    Meng F; Kaul D; Thangaswamy S; Bhutoria S; Gerfen G; Branch C; Intaglietta M; Acharya SA
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):73-82. PubMed ID: 30663492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tin protoporphyrin activates the oxidant-dependent NRF2-cytoprotective pathway and mitigates acute kidney injury.
    Johnson ACM; Delrow JJ; Zager RA
    Transl Res; 2017 Aug; 186():1-18. PubMed ID: 28586635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease.
    Sparkenbaugh EM; Chen C; Brzoska T; Nguyen J; Wang S; Vercellotti GM; Key NS; Sundd P; Belcher JD; Pawlinski R
    Blood; 2020 May; 135(20):1783-1787. PubMed ID: 31977004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.